Global Chronic Kidney Disease (CKD) Drugs Market Set to Surpass USD 22.56 Billion by 2032 as Cardiorenal-Metabolic Therapies and Disease-Modifying Breakthroughs Reshape Nephrology
PUNE, INDIA — The global clinical nephrology landscape is witnessing a foundational transition from symptomatic, late-stage disease management toward early, proactive disease modification. According to a...
0 Comments
0 Shares
256 Views
Sngine France : Partagez Vos Moments, Faites de Nouveaux Amishttps://sngine.fr